CardioDx heart disease test wins Medicare coverage

A key national Medicare contractor will cover the cost of a coronary artery disease test developed by CardioDx Inc. The decision disclosed Tuesday by Palmetto GBA, a national contractor that administers Medicare benefits in Columbia, S.C., means that Medicare will cover the test for as many as 40 million enrollees. Coverage is retroactive to Jan. 1.